296 related articles for article (PubMed ID: 25377296)
1. Innovative pharmacotherapies for women with overactive bladder: where are we now and what is in the pipeline?
Sacco E; Bientinesi R
Int Urogynecol J; 2015 May; 26(5):629-40. PubMed ID: 25377296
[TBL] [Abstract][Full Text] [Related]
2. Early investigational β3 adreno-receptor agonists for the management of the overactive bladder syndrome.
Thiagamoorthy G; Giarenis I; Cardozo L
Expert Opin Investig Drugs; 2015; 24(10):1299-306. PubMed ID: 26292923
[TBL] [Abstract][Full Text] [Related]
3. Drug therapy of overactive bladder--what is coming next?
Andersson KE
Korean J Urol; 2015 Oct; 56(10):673-9. PubMed ID: 26495067
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological approach to overactive bladder and urge urinary incontinence in women: an overview.
Cipullo LM; Cosimato C; Filippelli A; Conti V; Izzo V; Zullo F; Guida M
Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():27-34. PubMed ID: 24411952
[TBL] [Abstract][Full Text] [Related]
5. Perspectives for the pharmacological treatment of overactive bladder syndrome.
Wróbel A; Kluz T; Surkont G; Wlaźlak E; Miotła P; Skorupska K; Rechberger T
Ginekol Pol; 2017; 88(9):504-508. PubMed ID: 29057437
[TBL] [Abstract][Full Text] [Related]
6. Emerging drugs for overactive bladder.
Karmarkar R; Khullar V
Expert Opin Emerg Drugs; 2015; 20(4):613-24. PubMed ID: 26359223
[TBL] [Abstract][Full Text] [Related]
7. [New pharmacological treatment concepts for overactive bladder].
Michel MC
Urologe A; 2003 Jun; 42(6):807-11. PubMed ID: 12851772
[TBL] [Abstract][Full Text] [Related]
8. Beyond Antimuscarinics: A Review of Pharmacological and Interventional Options for Overactive Bladder Management in Men.
De Nunzio C; Brucker B; Bschleipfer T; Cornu JN; Drake MJ; Fusco F; Gravas S; Oelke M; Peyronnet B; Tutolo M; van Koeveringe G; Madersbacher S
Eur Urol; 2021 Apr; 79(4):492-504. PubMed ID: 33402296
[TBL] [Abstract][Full Text] [Related]
9. Current and future pharmacotherapy for treating overactive bladder.
Thiagamoorthy G; Cardozo L; Robinson D
Expert Opin Pharmacother; 2016 Jul; 17(10):1317-25. PubMed ID: 27253972
[TBL] [Abstract][Full Text] [Related]
10. Emerging drugs for treatment of overactive bladder and detrusor overactivity.
Drake MJ
Expert Opin Emerg Drugs; 2008 Sep; 13(3):431-46. PubMed ID: 18764721
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Tolerability of Mirabegron Compared with Antimuscarinic Monotherapy or Combination Therapies for Overactive Bladder: A Systematic Review and Network Meta-analysis.
Kelleher C; Hakimi Z; Zur R; Siddiqui E; Maman K; Aballéa S; Nazir J; Chapple C
Eur Urol; 2018 Sep; 74(3):324-333. PubMed ID: 29699858
[TBL] [Abstract][Full Text] [Related]
12. Management of overactive bladder syndrome.
Srikrishna S; Robinson D; Cardozo L; Vella M
Postgrad Med J; 2007 Jul; 83(981):481-6. PubMed ID: 17621619
[TBL] [Abstract][Full Text] [Related]
13. Potential Future Pharmacological Treatment of Bladder Dysfunction.
Andersson KE
Basic Clin Pharmacol Toxicol; 2016 Oct; 119 Suppl 3():75-85. PubMed ID: 26990140
[TBL] [Abstract][Full Text] [Related]
14. Current management and future perspectives of overactive bladder (OAB) pharmacotherapy.
Dobrek Ł; Juszczak K; Wyczółkowski M; Thor PJ
Acta Pol Pharm; 2011; 68(6):807-21. PubMed ID: 22125944
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Combination Pharmacotherapy for Patients with Overactive Bladder: A Rapid Evidence Assessment.
Gratzke C; Chapple C; Mueller ER; Robinson D; Rolland C; Staskin D; Stoelzel M; Maanen RV; Siddiqui E
Eur Urol; 2019 Dec; 76(6):767-779. PubMed ID: 31416636
[TBL] [Abstract][Full Text] [Related]
16. [The new era in the pharmacological treatment of overactive bladder (OAB): mirabegron--a new selective beta3agonist].
Rechberger T; Kulik-Rechberger B; Miotła P; Wróbel A
Ginekol Pol; 2014 Mar; 85(3):214-9. PubMed ID: 24783434
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin injections for adults with overactive bladder syndrome.
Duthie JB; Vincent M; Herbison GP; Wilson DI; Wilson D
Cochrane Database Syst Rev; 2011 Dec; (12):CD005493. PubMed ID: 22161392
[TBL] [Abstract][Full Text] [Related]
18. Overactive bladder treatments in early phase clinical trials.
Colli E; Digesu GA; Olivieri L
Expert Opin Investig Drugs; 2007 Jul; 16(7):999-1007. PubMed ID: 17594185
[TBL] [Abstract][Full Text] [Related]
19. Treatment of overactive bladder symptoms beyond antimuscarinics: current and future therapies.
Ellsworth P
Postgrad Med; 2012 May; 124(3):16-27. PubMed ID: 22691895
[TBL] [Abstract][Full Text] [Related]
20. Current and emerging investigational medical therapies for the treatment of overactive bladder.
Tiwari A; Naruganahalli KS
Expert Opin Investig Drugs; 2006 Sep; 15(9):1017-37. PubMed ID: 16916270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
